SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Wilsher M, Hopkins R, Zeng I et al. Prevalence of asthma and atopy in sarcoidosis. Respirology 2012; 17: 28590.
  • 2
    Zissel G, Prasse A, Muller-Quernheim J. Immunologic response of sarcoidosis. Semin. Respir. Crit. Care Med. 2010; 31: 390403.
  • 3
    Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N. Engl. J. Med. 2007; 357: 215365.
  • 4
    Facco M, Cabrelle A, Teramo A et al. Sarcoidosis is a TH1/TH17 multisystem disorder. Thorax 2011; 66: 14450.
  • 5
    Rappl G, Pabst S, Riemann D et al. Regulatory T cells with reduced repressor capacities are extensively amplified in pulmonary sarcoid lesions and sustain granuloma formation. Clin. Immunol. 2011; 140: 7183.
  • 6
    Braga M, Quecchia C, Cavallucci E et al. T regulatory cells in allergy. Int. J. Immunopathol. Pharmacol. 2011; 24: 55S64S.
  • 7
    Baughman RP, Shipley R, Desai S et al. Changes in chest roentgenogram of sarcoidosis patients during a clinical trial of infliximab therapy: comparison of different methods of evaluation. Chest 2009; 136: 52635.
  • 8
    Judson MA, Baughman RP, Costabel U et al. Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur. Respir. J. 2008; 31: 118996.
  • 9
    Antoniu SA. Targeting the TNF-α pathway in sarcoidosis. Expert Opin. Ther. Targets 2010; 14: 219.
  • 10
    Massara A, Cavazzini L, La Corte R et al. Sarcoidosis appearing during anti- TNF-α therapy: a new ‘class effect’ paradoxical phenomenon. Two case reports and literature review. Semin. Arthritis Rheum. 2010; 39: 31319.
  • 11
    Toussirot E, Pertuiset E, Kantelip B et al. Sarcoidosis occurring during anti-TNF-α treatment for inflammatory rheumatic disease: report of two cases. Clin. Exp. Rheumatol. 2008; 26: 4715.
  • 12
    Ishiguro T, Takayanagi N, Kurashima K et al. Development of sarcoidosis during etanercept therapy. Intern Med. 2008; 47: 10215.
  • 13
    Kanellopoulou T, Filiotou A, Kranidioti H et al. Sarcoid-like granulomatosis in patients treated with anti- TNF-α factors. A case report and review of the literature. Clin. Rheumatol. 2011; 30: 5813.
  • 14
    Niimi T, Tomita H, Sato S et al. Bronchial responsiveness and angiotensin-converting enzyme gene polymorphism in sarcoidosis patients. Chest 1998; 114: 4959.
  • 15
    Marcias S, Ledda MA, Perra R et al. Aspecific bronchial hyperreactivity in pulmonary sarcoidosis. Sarcoidosis 1994; 11: 11822.
  • 16
    Nowak D, Kanzow G, Magnussen H. Patients with sarcoidosis frequently have bronchial hyperreactivity. Pneumologie 1990; 44: 5723.
  • 17
    Joint statement of the American Thoracic Society, the European Respiratory Society and the World Association of Sarcoidosis and Other Granulomatous Disorders. Statement on sarcoidosis. Am. J. Respir. Crit. Care Med. 1999; 160: 73655.
  • 18
    Hansell DM, Milne DG, Wilsher ML et al. Pulmonary sarcoidosis: morphologic associations of airflow obstruction at thin-section CT. Radiology 1998; 209: 697704.
  • 19
    Polychronopoulos VS, Prakash UBS. Airway involvement in sarcoidosis. Chest 2009; 136: 137180.
  • 20
    Boulet LP, Milot J, La Forge J et al. Lymphocytic alveolitis and airway responsiveness in recently diagnosed sarcoidosis. Sarcoidosis 1992; 9: 438.